Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check2 days agoChange DetectedAdded new history entries for 2026-01-08 and 2026-01-09, including a Study Status update and Revision: v3.3.4, and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedA new 'Study Status' entry was added to the version history for 2025-12-24. An older 2025-12-17 entry was removed.SummaryDifference0.2%

- Check24 days agoChange DetectedAdded a Study Status entry and updated to revision v3.3.3 (2025-12-17); removed the HHS Vulnerability Disclosure link (2025-12-01, v3.3.2).SummaryDifference0.2%

- Check45 days agoChange DetectedVersion adds Contacts/Locations and Study Status sections (84 locations) and removes the 2025-10-31 entry.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the Record History page; no study data or content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRemoved the government funding/status notice that previously appeared on the page.SummaryDifference0.3%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.